Cite
Molecular and Clinical Features of the Myeloproliferative Neoplasm Associated with JAK2 Exon 12 Mutations: a European Multicenter Study
MLA
Jean-Jacques Kiladjian, et al. “Molecular and Clinical Features of the Myeloproliferative Neoplasm Associated with JAK2 Exon 12 Mutations: A European Multicenter Study.” Blood, vol. 114, Nov. 2009, p. 3904. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........de554cbc80b0a17bca5abf7caa933acd&authtype=sso&custid=ns315887.
APA
Jean-Jacques Kiladjian, Francesco Passamonti, François Girodon, Eric Lippert, Carles Besses, Mario Cazzola, Chiara Elena, Cristiana Pascutto, Alessandro M. Vannucchi, Marco Ruggeri, Mary Frances McMullin, Susanne Schnittger, Torsten Haferlach, & Elisa Rumi. (2009). Molecular and Clinical Features of the Myeloproliferative Neoplasm Associated with JAK2 Exon 12 Mutations: a European Multicenter Study. Blood, 114, 3904.
Chicago
Jean-Jacques Kiladjian, Francesco Passamonti, François Girodon, Eric Lippert, Carles Besses, Mario Cazzola, Chiara Elena, et al. 2009. “Molecular and Clinical Features of the Myeloproliferative Neoplasm Associated with JAK2 Exon 12 Mutations: A European Multicenter Study.” Blood 114 (November): 3904. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........de554cbc80b0a17bca5abf7caa933acd&authtype=sso&custid=ns315887.